Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Epoxide Hydrolase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104531630B enables high-enantioselectivity enzyme mutants. Achieve substantial cost reduction in pharma intermediates manufacturing with scalable biocatalysis.
Patent CN103013945B details a novel epoxide hydrolase mutant enhancing hydrolytic activity and enantioselectivity for beta-blocker synthesis, offering significant cost and supply chain advantages.